2004: Master of Medicine, University of Copenhagen, Denmark and authorization as a physician; 2006: Permission to practice independently as a physician (full registration); 2013: Specialist in Clinical Pharmacology (aut. ID: 05HN6), The Danish National Board of Health; 2014: PhD in health science (Thesis ISBN: 978-87-92613-44-8), University of Copenhagen; 2016: Leadership Programme (6 modules, 14 days)), Capital Region of Denmark: 2021: Research Management Course (6 modules, 9½ days), CBS Executive Fonden.

2004: Resident, Department of Internal Medicin, Koege Hospital, University of Copenhagen, Denmark; 2004-2005: Resident, Department of Orthopedic Surgery, Koege Hospital, University of Copenhagen, Denmark; 2005-2005: GP resident, Solroed Strand, Denmark; 2006-2007: Several short term GP resident positions, Various places in Norway; 2006-2007: Resident physician, Department of Internal Medicine F, Gentofte Hospital University of Copenhagen, Denmark; 2007-2008: Resident physician, Department of Internal Medicine, Amager Hospital University of Copenhagen, Denmark; 2007-2008: Physician, Senior Resident, Department of Clinical Pharmacology, Bispebjerg Hospital,University of Copenhagen, Denmark; 2008-2016: Medical Expert in authorization of medicinal products (10 hours weekly), Danish Medicines Agency; 2009-2010: Clinical Research Assistant, Center for Diabetes Research, Gentofte University Hospital; 2010: Physician, Senior Resident, Department of Hematology, Rigshospitalet, University of Copenhagen, Denmark; 2010-2012: Clinical Research Assistant, Center for Diabetes Research, Gentofte Hospital, University of Copenhagen, Denmark; 2012-2013: Physician, Senior Resident, Department of Clinical Pharmacology, Bispebjerg Hospital; 2013-2013: Physician, Senior Resident, Department of Internal Medicine, Gentofte Hospital; 2013-present: Chief Physician, Head of Education, Department of Clinical Pharmacology, Bispebjerg Hospital; 2013-present: Clinical Associate Professor, University of Copenhagen and Bispebjerg Hospital; 2018-present: Postgraduate Associate Professor, Eastern Region of Denmark & University of Copenhagen; 2020-present: Head of Copenhagen Centre for Translationel Research, Bispebjerg and Frederiksberg Hospital.

Head of Copenhagen Centre for Translational Research (60% position at Department of Biochemistry Bispebjerg and Frederiksberg Hospital) & Chief Physician and Clinical Associate Professor (40% position at at the Department of Clinical Pharmacology, Bispebjerg Hospital). Responsibilities include Research management of translational research and phase one clinical trials (Zelo Phase one trial unit), medication reviews at outpatient clinics, function as a clinical toxicologist on-call at the national poison information center (Giftlinjen).

Dr. Mikkel Christensen is involved in several national and regional councils that evaluate pharmacotherapy and thereby impact rational use of medicines in Denmark. Ongoing from 2014: Chairman of the endocrinology group by the Capital Region’s Medicines Committee (Den Regionale Lægemiddelkomite). Ongoing from 2016: Part of working group National Recommendation List (Den Nationale Rekommandationsliste) from the Danish Health Authority (Sundhedsstyrelsen) appointed by Danish Society of Clinical Pharmacology. From 2019: Member of the national Danish Medicines Council (Medicinrådet) “workgroup on type 2 diabetes” appointed by Danish Society of Clinical Pharmacology.

Awards: Awarded talent price from the Bagger-Sørensen foundation (2015), Young investigator of the year, Scandinavian Society for the Study of Diabetes (2012); Grants: Research grants from the Capital region of Denmark, University of Copenhagen, Danish Diabetes Association, Beckett-foundation and Tryg Foundation - total funding amounting to > € 2,000,000.

Research primarily within the areas: Clinical pharmacology, polypharmacy, medication review, diabetology, and medicines safety/toxicology (see full publication list on Google Scholar: Mikkel Christensen). Author of several textbook chapters and >120 scientific publications (68 original articles, 34 scientific reviews/proceedings, 25 commentaries/editorials/letters/case reports). >100 Danish and international scientific presentations. Impact Citations: ~ Citations: ~ 4279 (Google Scholar), ~2.671 (Web of Science). H-indices: 30 (Google Scholar), 29 (Web of Science); Scopus Author ID: 32067543900; ResearcherID: H-5861-2013; https://orcid.org/0000-0002-8774-1797

Supervisor for 17 PhD students - 4 as primary supervisor (1 completed) and 13 as co-supervisor (4 completed) in clinical pharmacology, metabolism and toxicology. Extensive pre- and postgraduate teaching experience in physiology, pharmacology, toxicology and diabetology. Since 2013 clinical associate professor responsible for lectures, teaching and examination at University of Copenhagen course in clinical pharmacology (30 hours annually).

Ongoing since 2008, I have been an active researcher in topics relating to clinical metabolism and pharmacology. My metabolic research has contributed significantly to understanding the action of endogenous hormones in diabetes and postprandial metabolism, particularly glucose and bone homeostasis and appetite regulation in humans. I am are currently exploring interventions to avoid hypoglycemia in patients with diabetes. My research has among other things led to a patent (WO2016034186A1) that is currently investigated as treatment against obesity and other metabolic disorders.
Since 2013 I have described various aspects and challenges with polypharmacy and how to deal with this by revising medication lists (Medication reviews). In 2017, I obtained funding to and initiated the Polypharmacy Outpatient Clinic at Bispebjerg and Frederiksberg Hospital. This clinic is now responsible for reviewing medications in complex patients with multiple diseases and pharmacological treatments and have shown great results with regards to improvements in pharmacotherapy and health-related quality of life (results awaiting publication).